Korean J Urol.  2002 Feb;43(2):112-116.

The Prognostic Difference between the Invasive Bladder Cancer at the Initial Diagnosis and the Invasive Bladder Cancer Progressed from Superficial

Affiliations
  • 1Department of Urology, College of Medicine, Korea University, Seoul, Korea.

Abstract

PURPOSE
This study evaluated the prognostic differences in invasive cancer that progressed from a superficial transitional cell carcinoma (TCC) compared to an already invasive TCC at the time of the initial presentation.
MATERIALS AND METHODS
Seventy-one patients who had a radical cystectomy performed for an invasive TCC were enrolled in this study. They were divided into two groups. In the first group, the patients were diagnosed as a superficial TCC at initially, which progressed to an invasive tumor. The second group consisted of patients who were diagnosed with invasive TCC at the time of the initial diagnosis. Two groups were compared with regard to the TNM stage, Ash grade, presence of accompanying carcinoma in-situ and survival rate.
RESULTS
The group with invasive cancer at the time of the initial presentation had a significantly higher grade than the progressed group. The five-year survival rate was lower in the progressed group. Moreover, Kaplan-Meier analysis showed it was statistically significant (p=0.04).
CONCLUSIONS
The grade was higher and the five-year survival rate was lower in the group with invasive cancer at the time of the initial presentation. Therefore, the invasive TCC at the initial diagnosis might take a more aggressive nature than the progressed group.

Keyword

Urinary bladder; Transitonal cell carcinoma; Invasive; Superficial; Prognosis

MeSH Terms

Carcinoma, Transitional Cell
Cystectomy
Diagnosis*
Humans
Kaplan-Meier Estimate
Prognosis
Survival Rate
Urinary Bladder Neoplasms*
Urinary Bladder*
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr